These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 1525324)

  • 21. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women.
    Stanford JL; Weiss NS; Voigt LF; Daling JR; Habel LA; Rossing MA
    JAMA; 1995 Jul; 274(2):137-42. PubMed ID: 7596001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis.
    Reeves GK; Beral V; Green J; Gathani T; Bull D;
    Lancet Oncol; 2006 Nov; 7(11):910-8. PubMed ID: 17081916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is breast cancer risk the same for all progestogens?
    Stute P
    Arch Gynecol Obstet; 2014 Aug; 290(2):207-9. PubMed ID: 24838289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breast cancer risk after estrogen replacement therapy: results from the Toronto Breast Cancer Study.
    Palmer JR; Rosenberg L; Clarke EA; Miller DR; Shapiro S
    Am J Epidemiol; 1991 Dec; 134(12):1386-95; discussion 1396-401. PubMed ID: 1663701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hormone replacement therapy in menopause and risk of breast cancer].
    Clavel-Chapelon F; Hill C
    Presse Med; 2000 Oct; 29(31):1688-93. PubMed ID: 11094609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risks of breast and endometrial cancer after estrogen and estrogen-progestin replacement.
    Persson I; Weiderpass E; Bergkvist L; Bergström R; Schairer C
    Cancer Causes Control; 1999 Aug; 10(4):253-60. PubMed ID: 10482483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer incidence and mortality in women receiving estrogen and estrogen-progestin replacement therapy--long-term follow-up of a Swedish cohort.
    Persson I; Yuen J; Bergkvist L; Schairer C
    Int J Cancer; 1996 Jul; 67(3):327-32. PubMed ID: 8707404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP Diet and Health Study Cohort.
    Lacey JV; Brinton LA; Leitzmann MF; Mouw T; Hollenbeck A; Schatzkin A; Hartge P
    J Natl Cancer Inst; 2006 Oct; 98(19):1397-405. PubMed ID: 17018786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does post-menopausal hormone-replacement therapy increase risk for breast cancer? A perspective on the findings of the Nurses' Health Study.
    Herd JA; Gotto AM
    Pharmacol Res; 1995 Dec; 32(6):331-3. PubMed ID: 8736483
    [No Abstract]   [Full Text] [Related]  

  • 30. Menopausal hormone therapy and risk of melanoma: Do estrogens and progestins have a different role?
    Botteri E; Støer NC; Sakshaug S; Graff-Iversen S; Vangen S; Hofvind S; Ursin G; Weiderpass E
    Int J Cancer; 2017 Nov; 141(9):1763-1770. PubMed ID: 28685818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased risk of breast cancer following different regimens of hormone replacement therapy frequently used in Europe.
    Stahlberg C; Pedersen AT; Lynge E; Andersen ZJ; Keiding N; Hundrup YA; Obel EB; Ottesen B
    Int J Cancer; 2004 May; 109(5):721-7. PubMed ID: 14999781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Menopausal hormone usage and breast cancer in Saskatchewan: a record-linkage cohort study.
    Risch HA; Howe GR
    Am J Epidemiol; 1994 Apr; 139(7):670-83. PubMed ID: 8166128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Re: Breast cancer risk in relation to the interval between menopause and starting hormone therapy.
    Grant EC
    J Natl Cancer Inst; 2011 Jul; 103(13):1069; reply 1069-70. PubMed ID: 21700925
    [No Abstract]   [Full Text] [Related]  

  • 34. Exogenous progestins and breast cancer.
    Stanford JL; Thomas DB
    Epidemiol Rev; 1993; 15(1):98-107. PubMed ID: 8405216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does hormone replacement therapy cause breast cancer? An application of causal principles to three studies: part 3. The Women's Health Initiative: unopposed estrogen.
    Shapiro S; Farmer RD; Mueck AO; Seaman H; Stevenson JC
    J Fam Plann Reprod Health Care; 2011 Oct; 37(4):225-30. PubMed ID: 21642263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breast cancer risk by breast density, menopause, and postmenopausal hormone therapy use.
    Kerlikowske K; Cook AJ; Buist DS; Cummings SR; Vachon C; Vacek P; Miglioretti DL
    J Clin Oncol; 2010 Aug; 28(24):3830-7. PubMed ID: 20644098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.
    Ross RK; Paganini-Hill A; Wan PC; Pike MC
    J Natl Cancer Inst; 2000 Feb; 92(4):328-32. PubMed ID: 10675382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estrogen replacement therapy and risk of fatal breast cancer in a prospective cohort of postmenopausal women in the United States.
    Willis DB; Calle EE; Miracle-McMahill HL; Heath CW
    Cancer Causes Control; 1996 Jul; 7(4):449-57. PubMed ID: 8813433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer.
    Colditz GA
    J Natl Cancer Inst; 1998 Jun; 90(11):814-23. PubMed ID: 9625169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exogenous hormone use and the risk of postmenopausal breast cancer: results from The Netherlands Cohort Study.
    Schuurman AG; van den Brandt PA; Goldbohm RA
    Cancer Causes Control; 1995 Sep; 6(5):416-24. PubMed ID: 8547539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.